These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 18195571
1. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5. Lin YL, Mettling C, Portalès P, Rouzier R, Clot J, Reynes J, Corbeau P. AIDS; 2008 Jan 30; 22(3):430-2. PubMed ID: 18195571 [Abstract] [Full Text] [Related]
2. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. Jalonen TO, Pulkkinen K, Ukkonen M, Saarela M, Elovaara I. J Neurol; 2002 May 30; 249(5):576-83. PubMed ID: 12021948 [Abstract] [Full Text] [Related]
3. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density. Desmetz C, Lin YL, Mettling C, Portalès P, Rabesandratana H, Clot J, Corbeau P. Immunology; 2006 Dec 30; 119(4):551-61. PubMed ID: 17177831 [Abstract] [Full Text] [Related]
4. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production. Blaak H, Ran LJ, Rientsma R, Schuitemaker H. Virology; 2000 Feb 15; 267(2):237-46. PubMed ID: 10662619 [Abstract] [Full Text] [Related]
5. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling. Lin YL, Mettling C, Portalès P, Réant B, Robert-Hebmann V, Reynes J, Clot J, Corbeau P. AIDS; 2006 Jun 26; 20(10):1369-77. PubMed ID: 16791011 [Abstract] [Full Text] [Related]
10. In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases. Sekerova V, Subrtova D, Mrazek F, Gibejova A, Kolek V, du Bois RM, Petrek M. Mediators Inflamm; 2003 Aug 26; 12(4):215-20. PubMed ID: 14514472 [Abstract] [Full Text] [Related]
11. CCL5/CCR5 axis promotes the motility of human oral cancer cells. Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, Lin YT, Hsu CJ, Fong YC, Tang CH. J Cell Physiol; 2009 Aug 26; 220(2):418-26. PubMed ID: 19334035 [Abstract] [Full Text] [Related]
14. Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia. Li Q, Wang D, Wang Y, Xu Q. Transplant Proc; 2006 Nov 26; 38(9):2899-904. PubMed ID: 17112859 [Abstract] [Full Text] [Related]
17. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA. Qureshi A, Zheng R, Parlett T, Shi X, Balaraman P, Cheloufi S, Murphy B, Guntermann C, Eagles P. Biochem J; 2006 Mar 01; 394(Pt 2):511-8. PubMed ID: 16293105 [Abstract] [Full Text] [Related]
18. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S. J Clin Virol; 2008 Sep 01; 43(1):25-31. PubMed ID: 18462992 [Abstract] [Full Text] [Related]
20. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES. Nisius L, Rogowski M, Vangelista L, Grzesiek S. Protein Expr Purif; 2008 Oct 01; 61(2):155-62. PubMed ID: 18588983 [Abstract] [Full Text] [Related] Page: [Next] [New Search]